These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6636145)

  • 21. [HBeAg-anti-HBe markers in HBsAg carriers among volunteer donors].
    Nikiforova TV; Kulikova MM
    Gematol Transfuziol; 1985 Nov; 30(11):61-3. PubMed ID: 4085772
    [No Abstract]   [Full Text] [Related]  

  • 22. HBeAg and anti-HBe detection by radioimmunoassay: correlation with vertical transmission of hepatitis B virus in Taiwan.
    Stevens CE; Neurath RA; Beasley RP; Szmuness W
    J Med Virol; 1979; 3(3):237-41. PubMed ID: 479860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The interrelationships of hepatitis B e antigen antibody and HBsAg-circulating immune complexes in asymptomatic HBsAg carriers].
    Chang ML; Chou CT; Lee CF; Chang DM
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1988 Nov; 21(4):224-9. PubMed ID: 3256466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [HBeAg and anti-HBe in asymptomatic carriers of HBsAg and in various forms of hepatitis and liver cirrhosis].
    Kalinowska B; Nazarewicz-de Mezer T; Krawczyński K
    Przegl Epidemiol; 1984; 38(3):249-56. PubMed ID: 6528039
    [No Abstract]   [Full Text] [Related]  

  • 25. Frequency of concurrence of hepatitis B surface antigen and antibody in a large number of carriers in Okinawa, Japan.
    Hayashi J; Noguchi A; Nakashima K; Morofuji M; Kashiwagi S
    Gastroenterol Jpn; 1990 Oct; 25(5):593-7. PubMed ID: 2227250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IgG subclasses in circulating immune complexes with hepatitis B e antigen in chronic hepatitis B.
    Sällberg M; Norder H; Lindh G; Magnius LO
    Clin Exp Immunol; 1991 Apr; 84(1):116-21. PubMed ID: 2015701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [e/Anti-e system in liver disease].
    Resta ML; Freni MA; Berlinghieri G; Ajello A; Crinò M; Ferraù O
    Boll Soc Ital Biol Sper; 1980 Oct; 56(20):2123-8. PubMed ID: 7459125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sex difference in chronic hepatitis B virus infection: an appraisal based on the status of hepatitis B e antigen and antibody.
    Chu CM; Liaw YF; Sheen IS; Lin DY; Huang MJ
    Hepatology; 1983; 3(6):947-50. PubMed ID: 6313507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [HBe antigen and its antibodies in HBsAg carriers in various regions of the USSR].
    Mikhaĭlov MI; Arakelov SA; Vorozhbieva TE; Zhavoronok SV; Zubov SV
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Jul; (7):71-4. PubMed ID: 3901627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B virus DNA in chronic HBsAg carriers: correlation with HBeAg/anti-HBe status, anti-HD and liver histology.
    Stroffolini T; Sagnelli E; Rapicetta M; Felaco FM; Filippini P; Annella T; Petruzziello A; Chionne P; Sarrecchia B; Piccinino F
    Hepatogastroenterology; 1992 Feb; 39(1):62-5. PubMed ID: 1568710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidences of HBeAg and anti-HBe in, and clinical course of hepatitis B virus carriers.
    Tsuchie H; Kurimura O; Tamura I; Shimase K; Kaneto E; Kurimura T; Tsuda F; Mayumi M
    Biken J; 1984 Dec; 27(4):169-76. PubMed ID: 6100353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigations of HBe antigen. Note I. Prevalence of HBeAg and anti-HBe in the stationary phase of HBsAg-positive acute viral hepatitis.
    Babeş VT; Tănase M; Cepănaru S; Cepănaru R
    Virologie; 1981; 32(2):93-8. PubMed ID: 6787796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Changes of HBeAg/anti-HBeAb system in chronic type B hepatitis, especially acute hepatitis from HBsAg carriers and persistent hepatitis].
    Kasajima M
    Nihon Shokakibyo Gakkai Zasshi; 1984 Jul; 81(7):1574-81. PubMed ID: 6492455
    [No Abstract]   [Full Text] [Related]  

  • 34. Investigations on HBe antigen. Note II. Dynamics of HBsAg in acute viral hepatitis, according to HBeAg persistence or seroconversion.
    Babeş VT; Cepănaru S; Cepănaru R; Tănase M
    Virologie; 1981; 32(3):187-91. PubMed ID: 7303492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of hepatitis B "e" antigen and its antibody in various HBsAg carrier populations.
    Szmuness W; Neurath AR; Stevens CE; Strick N; Harley EJ
    Am J Epidemiol; 1981 Feb; 113(2):113-21. PubMed ID: 7468569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis Be antigen and antibody in hepatitis B surface antigen positive blood donors.
    Barr A; Black SH; Burrell CJ; Dow B; Macvarish I
    J Clin Pathol; 1979 Feb; 32(2):132-5. PubMed ID: 108319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of HBeAg and anti-HBe among HBsAg carrier thai children.
    Pongpipat D; Suvatte V; Assateerawatts A
    J Med Assoc Thai; 1981 Nov; 64(11):562-7. PubMed ID: 7320671
    [No Abstract]   [Full Text] [Related]  

  • 38. Spontaneous loss of HBeAg and development of anti-HBe during long-term follow-up of blood donors found to be HBsAg-positive.
    Brown SD; Barbara AJ; Lambert T; Wilson DV
    Br J Biomed Sci; 1995 Jun; 52(2):106-9. PubMed ID: 8520247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-HBc titers in HBeAg and anti-HBe positive asymptomatic HBsAg carriers.
    Hess G; Wagner J; Arnold W; Purcell RH; Meyer zum Büschenfelde KH
    Z Immunitatsforsch Immunobiol; 1978 Jun; 154(3):208-17. PubMed ID: 676425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical significance of HBeAg and anti-HBe in HBsAg positive liver diseases].
    Takahashi A; Sekiya C; Yazaki Y; Tominaga Y; Oohara K; Ono M; Sato H; Hasebe C; Namiki M
    Hokkaido Igaku Zasshi; 1983 Jan; 58(1):30-42. PubMed ID: 6840666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.